Karyopharm Therapeutics | KPTI - Eps Utile Per Azione





Eps Cambiamento Data
AbbVie USD 3.82 0.17 2026-09
Abbott USD 0.53 0.78 2026-09
Amgen USD 6.45 0.16 2026-09
AstraZeneca USD 2.79 0.16 2026-09
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
Bristol-Myers Squibb USD 1.35 0.69 2026-09
Eli Lilly USD 7.48 0.9 2026-09
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
GlaxoSmithKline GBP 0.55 0.04 2026-09
Incyte USD -3.6 6.69 2026-09
J&J USD 2.7 0.2 2026-09
Karyopharm Therapeutics USD -1.02 1.2 2026-03
MacroGenics USD 0.31 0.89 2026-06
Merck USD 2.49 2.62 2026-09
Nektar Therapeutics USD -1.78 0.43 2026-03
Novartis USD 2.46 0.05 2026-09
Novartis USD 0.63 1.36 2026-09
Pfizer USD 0.87 0.1 2026-09
Regeneron Pharmaceuticals USD 20.07 5.78 2026-09
Roche Holding CHF 10.98 2.61 2026-06
Sangamo BioSciences USD -0.18 0.1 2024-06
Takeda JPY 116.95 45.3 2026-09
Tectonic Therapeutic USD -1.18 0.17 2026-06
TG Therapeutics USD 0.35 0.3 2026-09
Ultragenyx Pharmaceutical USD -1.16 0.26 2026-09
Xencor USD 0.5 0.79 2026-09